Erratum: Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
FONTE
J. Bras. Nefrol.
DATA DE PUBLICAÇÃO
01/08/2019
RESUMO
Documentos Relacionados
- Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus
- Periodontal parameters in prediabetes, type 2 diabetes mellitus, and non-diabetic patients
- Association of glycemic control with progression of diabetic retinopathy in type 2 diabetes mellitus patients in Malaysia
- Abnormal diastolic function in patients with type 1 diabetes and early nephropathy.
- Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus